Prof. Dr. Andrea Marino š has been serving as an Associate Professor in the field of Skin, Infectious, and Gastrointestinal Diseases since February 2023 at the National Scientific Qualification. š He is also pursuing a PhD in Basic and Applied Biomedical Sciences at the University of Catania, Italy, since November 2021. š§¬ Dr. Marino is an Infectious Diseases Specialist at the University of Messina since December 2021. š„ He has held a medical license from Ordine dei Medici Catania since March 2017. š Additionally, he earned his degree in Medicine from the University of Catania in July 2016. š©ŗ He has been an Italian Red Cross Volunteer since August 2012. š
WORK EXPERIENCE š¼
š¬ Assist Prof. Dr. Andrea Marino is an Assistant Professor/Senior Researcher in Infectious Diseases at the University of Catania, Italy, since May 2024. Previously, he was a Junior Researcher at the same institution. Since March 2020, he has been serving as a Medical Doctor for COVID-19 at ARNAS Garibaldi, Catania. Dr. Marino also completed his residency in Infectious Diseases at ARNAS Garibaldi (2017-2021) and received the SIMIT Research Grant in 2017. He is a Teaching Assistant, Editorial Board Member for multiple journals, and a Volunteer Reviewer at MDPI Journals. š¦ ššØāāļø
Editorial Board Member šš„
š¬ Assist Prof. Dr. Andrea Marino is a distinguished researcher contributing to PLOS ONE. š With a robust background in [specific research area], Dr. Marino excels in advancing scientific knowledge through innovative methodologies and rigorous analysis. š Their work focuses on [briefly describe research focus], aiming to address critical challenges and drive impactful discoveries. š Passionate about open-access science, Dr. Marino is dedicated to ensuring research findings are accessible to a global audience, fostering collaboration and knowledge sharing. š Their commitment to excellence and collaboration makes them a valuable asset to the scientific community. š¤š
PUBLICATION TOP NOTES š
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study
Mortality attributable to bloodstream infections caused by different carbapenem-resistant gram-negative bacilli: results from a nationwide study in Italy (ALARICO Network)
Malignant melanoma in HIV: Epidemiology, pathogenesis, and management
Profiles of multidrug-resistant organisms among patients with bacteremia in intensive care units: An international ID-IRI survey
Non-AIDS defining cancers: a comprehensive update on diagnosis and management.
Acinetobacter baumannii and Cefiderocol, between Cidality and Adaptability
Managing adult patients with infectious diseases in emergency departments: international ID-IRI study
Ampicillin Plus Ceftriaxone Regimen againstĀ Enterococcus faecalisĀ Endocarditis: A Literature Review
Rapid emergence of cryptococcal fungemia, Mycobacterium chelonae vertebral osteomyelitis and gastro intestinal stromal tumor in a young HIV late presenter: A case report